BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35419917)

  • 21. Long non-coding RNA FOXD2-AS1 functions as a tumor promoter in colorectal cancer by regulating EMT and Notch signaling pathway.
    Yang X; Duan B; Zhou X
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3586-3591. PubMed ID: 28925486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review on the role of FOXD2-AS1 in human disorders.
    Ghafouri-Fard S; Harsij A; Hussen BM; Pourmoshtagh H; Taheri M
    Pathol Res Pract; 2024 Feb; 254():155101. PubMed ID: 38211387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA FOXD2-AS1 enhances chemotherapeutic resistance of laryngeal squamous cell carcinoma via STAT3 activation.
    Li R; Chen S; Zhan J; Li X; Liu W; Sheng X; Lu Z; Zhong R; Chen L; Luo X; Hu Y; Ouyang Y; Liu T; Zhang Q; Zhang S
    Cell Death Dis; 2020 Jan; 11(1):41. PubMed ID: 31959918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells.
    Wu DM; Zheng ZH; Zhang YB; Fan SH; Zhang ZF; Wang YJ; Zheng YL; Lu J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):237. PubMed ID: 31171015
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Shangguan W; Lv X; Tian N
    Korean J Physiol Pharmacol; 2019 Nov; 23(6):475-482. PubMed ID: 31680769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumol inhibits malignant biological behaviors and TMZ-resistance in glioma cells by inhibiting long noncoding RNA FOXD2-As1-promoted EZH2 activation.
    Lv X; Sun J; Hu L; Qian Y; Fan C; Tian N
    Aging (Albany NY); 2021 Nov; 13(21):24101-24116. PubMed ID: 34739394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA NNT-AS1 promote glioma cell proliferation and metastases through miR-494-3p/PRMT1 axis.
    Zheng D; Chen D; Lin F; Wang X; Lu L; Luo S; Chen J; Xu X
    Cell Cycle; 2020 Jul; 19(13):1621-1631. PubMed ID: 32420808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA FOXD2-AS1 plays an oncogenic role in hepatocellular carcinoma through epigenetically silencing CDKN1B(p27) via EZH2.
    Xu K; Zhang Z; Qian J; Wang S; Yin S; Xie H; Zhou L; Zheng S
    Exp Cell Res; 2019 Jul; 380(2):198-204. PubMed ID: 31004581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA SNHG9 facilitates growth of glioma stem-like cells via miR-326/SOX9 axis.
    Wang CJ; Chao CR; Zhao WF; Liu HM; Feng JS; Cui YX
    J Gene Med; 2022 Jan; 24(1):e3334. PubMed ID: 33789359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of LncRNA FOXD2-AS1 by H3K27 acetylation regulates VEGF-A expression by sponging miR-205-5p in recurrent pterygium.
    Gao Y; Luo X; Zhang J
    J Cell Mol Med; 2020 Dec; 24(24):14139-14151. PubMed ID: 33098266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA FOXD2-AS1 induces chondrocyte proliferation through sponging miR-27a-3p in osteoarthritis.
    Wang Y; Cao L; Wang Q; Huang J; Xu S
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1241-1247. PubMed ID: 30945573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly expressed long non-coding RNA FOXD2-AS1 promotes non-small cell lung cancer progression via Wnt/β-catenin signaling.
    Rong L; Zhao R; Lu J
    Biochem Biophys Res Commun; 2017 Mar; 484(3):586-591. PubMed ID: 28132805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers.
    Hu Q; Tai S; Wang J
    Pathol Res Pract; 2019 May; 215(5):843-848. PubMed ID: 30723052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moderate Prognostic Value of lncRNA FOXD2-AS1 in Gastric Cancer with Helicobacter pylori Infection.
    Rajabi A; Bastani S; Maydanchi M; Tayefeh-Gholami S; Abdolahi S; Saber A; Safaralizadeh R
    J Gastrointest Cancer; 2022 Sep; 53(3):687-691. PubMed ID: 34478035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N
    Ren Z; Hu Y; Sun J; Kang Y; Li G; Zhao H
    Bioengineered; 2022 Apr; 13(4):7963-7973. PubMed ID: 35356854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA FOXD2-AS1 aggravates nasopharyngeal carcinoma carcinogenesis by modulating miR-363-5p/S100A1 pathway.
    Chen G; Sun W; Hua X; Zeng W; Yang L
    Gene; 2018 Mar; 645():76-84. PubMed ID: 29248577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIF-1α induced long noncoding RNA FOXD2-AS1 promotes the osteosarcoma through repressing p21.
    Ren Z; Hu Y; Li G; Kang Y; Liu Y; Zhao H
    Biomed Pharmacother; 2019 Sep; 117():109104. PubMed ID: 31228799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA FOXD2-AS1 promotes cell proliferation and invasion of fibroblast-like synoviocytes by regulation of miR-331-3p/PIAS3 pathway in rheumatoid arthritis.
    Zhao Q; Zhao F; Liu C; Xu T; Song K
    Autoimmunity; 2021 Aug; 54(5):254-263. PubMed ID: 34030529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FOXD2-AS1 correlates with the malignant status and regulates cell proliferation, migration, and invasion in cutaneous melanoma.
    Ren W; Zhu Z; Wu L
    J Cell Biochem; 2019 Apr; 120(4):5417-5423. PubMed ID: 30426532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA SOCS2-AS1 promotes the progression of glioma via regulating ITGB1 expression.
    Wu D; Sun J; Wang H; Ma C
    Neurosci Lett; 2021 Nov; 765():136248. PubMed ID: 34536509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.